Thursday, June 3 – Arlington, VA – The Digital Therapeutics Alliance (DTA) is pleased to welcome Owen McCarthy, President and Co-Founder of MedRhythms, to the DTA Board of Directors. In support of DTA’s work to transform global healthcare by advancing digital therapeutics (DTx), the Board provides critical guidance related to the strategy and direction of the organization.
The DTA Board of Directors includes:
“It is a great honor to serve on the DTA Board of Directors,” shares Owen McCarthy. “I look forward to building on my perspective as a DTx manufacturer to help us continue elevating the industry to reach the many patients that need us.”
As DTx industry leaders, DTA member efforts are instrumental in providing patients and caregivers, clinicians, policy and healthcare decision makers with reliable resources to meaningfully integrate digital therapeutics into practice and transform global healthcare.
About DTA
The Digital Therapeutics Alliance (DTA) is a global non-profit trade association of industry leaders and stakeholders with the mission of broadening the understanding and adoption of digital therapeutics into healthcare. DTA works to enable expanded access to high quality, evidence-based digital therapeutics for patients, clinicians, and payors in order to improve clinical and health economic outcomes. To learn more, please visit: www.dtxalliance.org.